Solid Biosciences Inc. (SLDB)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- -174,325,000
- Operating income
- -179,206,000
- Earnings per share
- -1.99
- R&D expense
- 140,325,000
Growth and profitability
- Return on equity
- -96.84
- Return on assets
- -74.97
Balance sheet
- Total assets
- 232,540,000
- Total liabilities
- 52,530,000
- Shareholders' equity
- 180,010,000
- Cash and equivalents
- 59,900,000
- Current ratio
- 6.14
Cash flow and ratios
- Operating cash flow
- -156,289,000
- Free cash flow
- -157,442,000
Shareholder returns
- Shares outstanding
- 111,610,531
- Book value per share
- 1.61
Company information
- Headquarters
- Charlestown, MA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Biological Products, (no Diagnostic Substances)
Fiscal year end: · Source: SEC EDGAR
Solid Biosciences Inc. trades on NASDAQ under the ticker symbol SLDB. This page brings together its price chart, company profile, key financial figures and technical indicators.